Nancy Mace said...

Do PBMs often exclude lower-cost generics in favor of high-cost branded drugs, effectively eliminating the benefit of the short patent on drugs?

Context

Mace questions the practices of PBMs regarding drug pricing.

09/18/2023

https://congress.gov...